Julia di Iulio

10.3k total citations
30 papers, 1.6k citations indexed

About

Julia di Iulio is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, Julia di Iulio has authored 30 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 14 papers in Molecular Biology and 6 papers in Virology. Recurrent topics in Julia di Iulio's work include HIV/AIDS drug development and treatment (10 papers), HIV Research and Treatment (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Julia di Iulio is often cited by papers focused on HIV/AIDS drug development and treatment (10 papers), HIV Research and Treatment (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Julia di Iulio collaborates with scholars based in United States, Switzerland and United Kingdom. Julia di Iulio's co-authors include Amalio Telenti, István Bartha, J. Craig Venter, Matthias Cavassini, Laurent A. Décosterd, L. Stirling Churchman, Rubin Lubomirov, Jeff Vierstra, J Stamatoyannopoulos and Richard Sandstrom and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Julia di Iulio

29 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia di Iulio United States 20 785 552 354 263 160 30 1.6k
Naiping Shen United States 5 784 1.0× 342 0.6× 228 0.6× 475 1.8× 52 0.3× 5 1.6k
Elizabeth D. Anton United States 14 1.1k 1.4× 442 0.8× 444 1.3× 205 0.8× 191 1.2× 21 1.7k
Silvana Opp United States 18 488 0.6× 287 0.5× 408 1.2× 89 0.3× 119 0.7× 31 1.1k
Michael K. Kießling Switzerland 14 854 1.1× 398 0.7× 1.1k 3.1× 208 0.8× 589 3.7× 25 2.3k
Ronna E. Dornsife United States 16 412 0.5× 613 1.1× 426 1.2× 117 0.4× 559 3.5× 25 1.4k
Lorraine Everitt United States 11 680 0.9× 504 0.9× 553 1.6× 122 0.5× 82 0.5× 12 1.3k
Krishnakumar Devadas United States 17 418 0.5× 155 0.3× 250 0.7× 69 0.3× 143 0.9× 40 890
Michael S. Boosalis United States 23 1.7k 2.2× 248 0.4× 107 0.3× 243 0.9× 104 0.7× 37 2.1k
Kirstin Stricker Switzerland 12 699 0.9× 163 0.3× 656 1.9× 83 0.3× 263 1.6× 21 1.6k
Itziar Erkizia Spain 18 458 0.6× 353 0.6× 632 1.8× 49 0.2× 263 1.6× 31 1.5k

Countries citing papers authored by Julia di Iulio

Since Specialization
Citations

This map shows the geographic impact of Julia di Iulio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia di Iulio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia di Iulio more than expected).

Fields of papers citing papers by Julia di Iulio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia di Iulio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia di Iulio. The network helps show where Julia di Iulio may publish in the future.

Co-authorship network of co-authors of Julia di Iulio

This figure shows the co-authorship network connecting the top 25 collaborators of Julia di Iulio. A scholar is included among the top collaborators of Julia di Iulio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia di Iulio. Julia di Iulio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Agostini, Maria L., Gretja Schnell, Julia di Iulio, et al.. (2024). Resistance analysis in the phase III COMET-TAIL study: treatment of COVID-19 with intramuscular or intravenous sotrovimab. Future Virology. 19(5). 185–198.
2.
Bartha, István, M. Cyrus Maher, Victor Lavrenko, et al.. (2024). Morbidity of SARS-CoV-2 in the evolution to endemicity and in comparison with influenza. SHILAP Revista de lepidopterología. 4(1). 244–244. 2 indexed citations
3.
Schnell, Gretja, Julia di Iulio, Anil Kumar Gupta, et al.. (2023). Resistance Analysis Following Sotrovimab Treatment in Participants with COVID-19 During the Phase III COMET-ICE Study. Future Virology. 18(15). 975–990. 2 indexed citations
4.
Maher, M. Cyrus, István Bartha, Steven Weaver, et al.. (2022). Predicting the mutational drivers of future SARS-CoV-2 variants of concern. Science Translational Medicine. 14(633). eabk3445–eabk3445. 99 indexed citations
5.
Iulio, Julia di, István Bartha, Roberto Spreafico, Herbert W. Virgin, & Amalio Telenti. (2021). Transfer transcriptomic signatures for infectious diseases. Proceedings of the National Academy of Sciences. 118(22). 8 indexed citations
6.
Pinsach‐Abuin, Mel·lina, Bernat del Olmo, Jesús Matés, et al.. (2021). Analysis of Brugada syndrome loci reveals that fine-mapping clustered GWAS hits enhances the annotation of disease-relevant variants. Cell Reports Medicine. 2(4). 100250–100250. 4 indexed citations
7.
Fischer, Jonathan, Yun S. Song, Nir Yosef, et al.. (2020). The yeast exoribonuclease Xrn1 and associated factors modulate RNA polymerase II processivity in 5‘ and 3‘ gene regions. Journal of Biological Chemistry. 295(33). 11435–11454. 20 indexed citations
8.
Heckerman, David, Ali Torkamani, Li Yin, et al.. (2019). Ranking of non-coding pathogenic variants and putative essential regions of the human genome. Nature Communications. 10(1). 52 indexed citations
9.
Dall’Agnese, Alessandra, Luca Caputo, Chiara Nicoletti, et al.. (2019). Transcription Factor-Directed Re-wiring of Chromatin Architecture for Somatic Cell Nuclear Reprogramming toward trans-Differentiation. Molecular Cell. 76(3). 453–472.e8. 61 indexed citations
10.
Bartha, István, Julia di Iulio, J. Craig Venter, & Amalio Telenti. (2017). Human gene essentiality. Nature Reviews Genetics. 19(1). 51–62. 146 indexed citations
11.
Telenti, Amalio, Levi Pierce, William Biggs, et al.. (2016). Deep sequencing of 10,000 human genomes. Proceedings of the National Academy of Sciences. 113(42). 11901–11906. 195 indexed citations
12.
Mayer, Andreas, Julia di Iulio, Seth Maleri, et al.. (2015). Native Elongating Transcript Sequencing Reveals Human Transcriptional Activity at Nucleotide Resolution. Cell. 161(3). 541–554. 256 indexed citations
13.
Mohammadi, Pejman, Julia di Iulio, Miguel Muñoz, et al.. (2014). Dynamics of HIV Latency and Reactivation in a Primary CD4+ T Cell Model. PLoS Pathogens. 10(5). e1004156–e1004156. 69 indexed citations
14.
Gaudieri, Silvana, Michaela Lucas, Andrew Lucas, et al.. (2012). Genetic Variations in IL28B and Allergic Disease in Children. PLoS ONE. 7(1). e30607–e30607. 19 indexed citations
15.
Iulio, Julia di, Angela Ciuffi, Karen Fitzmaurice, et al.. (2011). Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance. Hepatology. 53(5). 1446–1454. 48 indexed citations
16.
Buclin, Thierry, Laurent A. Décosterd, Cécile Delhumeau, et al.. (2011). Successful Efavirenz Dose Reduction Guided by Therapeutic Drug Monitoring. Antiviral Therapy. 16(2). 189–197. 28 indexed citations
17.
Merani, Shahzma, Danijela Petrović, Ian James, et al.. (2010). Effect of immune pressure on hepatitis C virus evolution: Insights from a single-source outbreak. Hepatology. 53(2). 396–405. 50 indexed citations
18.
Lubomirov, Rubin, Julia di Iulio, Aurélie Fayet, et al.. (2010). ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir. Pharmacogenetics and Genomics. 20(4). 217–230. 86 indexed citations
19.
Iulio, Julia di, Aurélie Fayet, Mona Arab‐Alameddine, et al.. (2009). In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function. Pharmacogenetics and Genomics. 19(4). 300–309. 120 indexed citations
20.
Arab‐Alameddine, Mona, Julia di Iulio, Thierry Buclin, et al.. (2009). Pharmacogenetics-Based Population Pharmacokinetic Analysis of Efavirenz in HIV-1-Infected Individuals. Clinical Pharmacology & Therapeutics. 85(5). 485–494. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naiping Shen Breakdown of academic impact, for papers by Elizabeth D. Anton Breakdown of academic impact, for papers by Silvana Opp Breakdown of academic impact, for papers by Michael K. Kießling Breakdown of academic impact, for papers by Ronna E. Dornsife Breakdown of academic impact, for papers by Lorraine Everitt Breakdown of academic impact, for papers by Krishnakumar Devadas Breakdown of academic impact, for papers by Michael S. Boosalis Breakdown of academic impact, for papers by Kirstin Stricker Breakdown of academic impact, for papers by Itziar Erkizia
Rankless by CCL
2026